Datopotamab Deruxtecan (Dato-DXd, DS-1062a)

datopotamab deruxtecan · Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Datopotamab Deruxtecan (Dato-DXd, DS-1062a), covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer [Phase 2]